Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-Q for the period ended Jun 30, 2013

Filed with the SEC on Aug 15, 2013 and accepted by EDGAR at Aug 14, 2013, 22:14 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Gross profit3 months2013-04-01 to 2013-06-30$451us-gaap:GrossProfit
Gross profit6 months2013-01-01 to 2013-06-30$857us-gaap:GrossProfit
Interest expense3 months2013-04-01 to 2013-06-30−$327us-gaap:InterestExpense
Interest expense6 months2013-01-01 to 2013-06-30−$650us-gaap:InterestExpense
Net income3 months2013-04-01 to 2013-06-30−$19.1kus-gaap:NetIncomeLoss
Net income6 months2013-01-01 to 2013-06-30−$22.4kus-gaap:NetIncomeLoss
Diluted EPS3 months2013-04-01 to 2013-06-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2013-01-01 to 2013-06-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2013-01-01 to 2013-06-30−$17.8kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2013-06-30$1.3kus-gaap:Cash
Current assetsAt period end2013-06-30$1.3kus-gaap:AssetsCurrent
Total assetsAt period end2013-06-30$1.3kus-gaap:Assets
Current liabilitiesAt period end2013-06-30$27.0kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-06-30$27.0kus-gaap:Liabilities
Shareholders' equityAt period end2013-06-30−$25.7kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001014897-13-000316. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.